microRNA-based autophagy inhibition as targeted therapy in pancreatic cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Pancreatic cancer has a very low survival rate.
• Pancreatic tumors rely on high autophagy levels for survival and progression.
• Autophagy dysfunction exacerbates tumor progression in pancreatic cancer.

Purpose of the Study:

• To review the mechanism of autophagy in pancreatic cancer.
• To explore recent advancements in autophagy inhibition for pancreatic cancer treatment.
• To focus on the microRNA-based approach for autophagy inhibition.

Main Methods:

• Review of existing literature on autophagy mechanisms.
• Analysis of studies investigating autophagy inhibitors (e.g., hydroxychloroquine, chloroquine).
• Examination of research on microRNA's role in targeting autophagy-related genes.

Main Results:

• Chemical autophagy inhibitors have shown limited therapeutic benefit as monotherapy.
• MicroRNA can effectively inhibit autophagy by targeting core autophagy-related genes.
• Autophagy inhibition enhances pancreatic tumor sensitivity to radiotherapy, chemotherapy, and targeted agents.

Conclusions:

• MicroRNA-based autophagy inhibition is a promising and feasible strategy for pancreatic cancer treatment.
• Targeting autophagy via microRNA can overcome resistance to conventional therapies.
• This approach holds potential for improving clinical outcomes in pancreatic cancer patients.